tiprankstipranks
Trending News
More News >
Astrana Health (ASTH)
NASDAQ:ASTH
US Market
Advertisement

Astrana Health (ASTH) Ratios

Compare
255 Followers

Astrana Health Ratios

ASTH's free cash flow for Q2 2025 was $0.11. For the 2025 fiscal year, ASTH's free cash flow was decreased by $ and operating cash flow was $0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.08 2.11 2.88 3.53 2.94
Quick Ratio
0.08 2.11 2.88 3.53 2.94
Cash Ratio
1.77 1.34 1.94 2.03 1.68
Solvency Ratio
0.24 0.15 0.15 0.24 -0.01
Operating Cash Flow Ratio
0.68 0.31 0.55 0.61 0.40
Short-Term Operating Cash Flow Coverage
7.33 3.50 132.68 90.17 4.24
Net Current Asset Value
$ -214.31M$ -61.09M$ 20.46M$ 47.74M$ -33.76M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.34 0.24 0.23 0.32
Debt-to-Equity Ratio
0.05 0.52 0.42 0.45 0.79
Debt-to-Capital Ratio
0.04 0.34 0.30 0.31 0.44
Long-Term Debt-to-Capital Ratio
0.04 0.30 0.27 0.29 0.41
Financial Leverage Ratio
1.36 1.52 1.78 1.94 2.47
Debt Service Coverage Ratio
1.79 2.58 8.34 11.17 14.69
Interest Coverage Ratio
2.22 5.25 13.16 18.20 2.41
Debt to Market Cap
0.03 0.15 0.15 0.06 0.36
Interest Debt Per Share
1.24 7.22 5.28 4.71 7.20
Net Debt to EBITDA
-2.77 0.22 -0.52 -0.32 0.33
Profitability Margins
Gross Profit Margin
11.53%15.50%17.43%22.97%5.86%
EBIT Margin
3.43%7.64%8.26%10.74%3.08%
EBITDA Margin
4.63%8.92%9.80%13.01%55.71%
Operating Profit Margin
2.90%6.10%9.11%12.69%1.64%
Pretax Profit Margin
2.12%6.48%7.57%10.05%2.40%
Net Profit Margin
1.04%4.38%3.95%8.91%-6.42%
Continuous Operations Profit Margin
1.14%4.17%4.00%5.95%-0.08%
Net Income Per EBT
49.19%67.58%52.15%88.65%-267.84%
EBT Per EBIT
73.28%106.18%83.07%79.19%145.71%
Return on Assets (ROA)
2.87%6.51%4.68%7.95%-2.91%
Return on Equity (ROE)
3.59%9.89%8.33%15.38%-7.18%
Return on Capital Employed (ROCE)
10.20%11.84%12.75%13.04%0.87%
Return on Invested Capital (ROIC)
9.88%7.37%6.70%7.69%-0.03%
Return on Tangible Assets
4.53%10.42%7.28%12.81%-4.83%
Earnings Yield
1.73%3.35%3.39%2.14%-3.56%
Efficiency Ratios
Receivables Turnover
6.62 9.39 9.56 7.79 6.11
Payables Turnover
149.36 129.11 90.20 108.13 36.48
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
75.49 31.11 8.87 11.28 7.64
Asset Turnover
2.75 1.49 1.18 0.89 0.45
Working Capital Turnover Ratio
63.77 5.31 4.02 3.02 1.66
Cash Conversion Cycle
52.67 36.06 34.15 43.46 49.75
Days of Sales Outstanding
55.11 38.89 38.20 46.84 59.76
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
2.44 2.83 4.05 3.38 10.01
Operating Cycle
55.11 38.89 38.20 46.84 59.76
Cash Flow Ratios
Operating Cash Flow Per Share
2.65 1.46 1.83 1.60 1.26
Free Cash Flow Per Share
2.40 0.85 1.32 1.17 1.23
CapEx Per Share
0.25 0.61 0.51 0.44 0.03
Free Cash Flow to Operating Cash Flow
0.91 0.58 0.72 0.73 0.97
Dividend Paid and CapEx Coverage Ratio
4.98 0.75 2.22 1.40 0.88
Capital Expenditure Coverage Ratio
10.54 2.39 3.58 3.66 39.66
Operating Cash Flow Coverage Ratio
4.44 0.21 0.36 0.35 0.18
Operating Cash Flow to Sales Ratio
0.05 0.05 0.07 0.09 0.12
Free Cash Flow Yield
7.99%2.19%4.45%1.59%6.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
57.70 29.83 29.46 46.73 -28.10
Price-to-Sales (P/S) Ratio
0.61 1.31 1.16 4.16 1.80
Price-to-Book (P/B) Ratio
2.25 2.95 2.45 7.19 2.02
Price-to-Free Cash Flow (P/FCF) Ratio
12.52 45.63 22.48 63.01 14.83
Price-to-Operating Cash Flow Ratio
11.16 26.55 16.20 45.79 14.46
Price-to-Earnings Growth (PEG) Ratio
-2.03 0.99 -0.81 -0.14 0.11
Price-to-Fair Value
2.25 2.95 2.45 7.19 2.02
Enterprise Value Multiple
10.43 14.86 11.35 31.68 3.56
Enterprise Value
1.17B 1.84B 1.27B 3.19B 734.45M
EV to EBITDA
10.43 14.86 11.35 31.68 3.56
EV to Sales
0.48 1.33 1.11 4.12 1.98
EV to Free Cash Flow
9.89 46.31 21.49 62.38 16.32
EV to Operating Cash Flow
8.95 26.95 15.49 45.33 15.91
Tangible Book Value Per Share
6.66 1.29 4.73 4.14 3.26
Shareholders’ Equity Per Share
13.18 13.15 12.06 10.23 9.06
Tax and Other Ratios
Effective Tax Rate
0.46 0.36 0.47 0.41 1.04
Revenue Per Share
49.18 29.69 25.44 17.66 10.14
Net Income Per Share
0.51 1.30 1.00 1.57 -0.65
Tax Burden
0.49 0.68 0.52 0.89 -2.68
Interest Burden
0.62 0.85 0.92 0.94 0.78
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.05 0.08 0.07 0.08 0.04
Stock-Based Compensation to Revenue
0.02 0.02 0.01 <0.01 <0.01
Income Quality
4.03 1.18 1.80 1.53 0.38
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis